EicOsis focuses on developing safe and effective, non-narcotic therapies for moderate to severe pain and inflammation in animals and man.
EicOsis is developing a first-in-class therapy of a once daily, oral treatment for neuropathic and inflammatory pain in humans and animals. Pain is an enormous emotional and economic burden. Current therapies have dose limiting side effects in addition to being ineffective in more than 3 of 4 patients. EicOsis discovered a novel enzyme target to alleviate pain without the dose limiting or narcotic side effects that exist in current treatments.